Best for: biomedical research ai agent
Biomni is a general-purpose biomedical AI agent that autonomously executes complex research workflows across diverse biomedical domains.
Run broad biomedical research tasks with an agent designed for multi-step scientific workflows.
Biomni is a general-purpose AI research assistant for biomedicine. It can help scientists plan and run complex research workflows across many areas of biology and medicine by combining literature/tool retrieval, reasoning, and code execution. Instead of relying on fixed templates, Biomni can assemble multi-step analyses dynamically, making it useful for tasks such as gene prioritization, drug repurposing, rare disease investigation, microbiome analysis, and protocol generation from real-world biomedical data.
Data is encrypted at rest. Attachments you upload into the agent workspace are deleted after a period of time, and we will notify you when that happens.
We recommend not uploading personally identifiable information or sensitive data.
QUESTION
🧬 For chronic myeloid leukemia (CML), return: 1) the hallmark fusion gene, 2) the chromosome translocation, 3) the first FDA-approved targeted drug for CML and its first approval year.
EXPECTED ANSWER
Fusion gene: BCR-ABL1 Translocation: t(9;22) (Philadelphia chromosome) First targeted drug: imatinib (Gleevec) FDA, first approval year: 2001
QUESTION
🦠 Create a mechanism-to-treatment summary for Methicillin-resistant Staphylococcus aureus (MRSA): 1) resistance gene, 2) altered protein target, 3) why most beta-lactams fail, 4) one beta-lactam that can still treat MRSA.
EXPECTED ANSWER
Resistance gene: mecA Altered target: PBP2a (penicillin-binding protein 2a) Failure reason: PBP2a has low affinity for most beta-lactam antibiotics Active beta-lactam: ceftaroline
Running this for a team? Book a demo or contact us.